Metacrine Inc (MTCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MTCR | CLDI | GOVX | ||
| Company | Metacrine Inc | Calidi Biotherapeutics Inc | Geovax Labs | ||
| Price Information | |||||
| Exchange | OTC US | NYSE Arca | NASDAQ | ||
| Open | 0.5883 | 2.20 | 2.62 | ||
| High | 0.5905 | 2.29 | 2.74 | ||
| Low | 0.5800 | 2.02 | 2.59 | ||
| Last | 0.5814 | 2.15 | 2.70 | ||
| Change | -0.0076 | -0.14 | +0.09 | ||
| % Change | -1.29% | -6.11% | +3.45% | ||
| Volume | 83,800 | 1,981,845 | 608,200 | ||
| 20-Day Average Volume | 57,870 | 3,668,930 | 3,535,605 | ||
| Previous Close | 0.5890 | 2.29 | 2.61 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.5659 | 1.75 | 2.33 | ||
| 20-Day Raw Stochastic | 88.35% | 44.94% | 44.60% | ||
| 20-Day Relative Strength | 55.86% | 57.31% | 52.79% | ||
| Weighted Alpha | +30.95 | -59.82 | -88.77 | ||
| Today's Opinion | 100% Buy | 8% Buy | Hold | ||
| Previous Opinion | 100% Buy | 8% Buy | 8% Sell | ||
| Last Month's Opinion | 88% Buy | 96% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.00% since 06/12/23 | +6.97% since 11/14/24 | +3.45% since 11/14/24 | ||
| Low | 0.5502 on 06/13/23 | 2.02 on 11/21/24 | 2.37 on 11/15/24 | ||
| High | 0.5905 on 06/20/23 | 2.51 on 11/19/24 | 3.12 on 11/18/24 | ||
| 1-Month | |||||
| %Chg | +2.43% since 05/19/23 | +90.27% since 10/21/24 | +20.54% since 10/21/24 | ||
| Low | 0.5124 on 05/30/23 | 0.73 on 10/25/24 | 1.75 on 11/04/24 | ||
| High | 0.5905 on 06/20/23 | 3.89 on 11/13/24 | 3.88 on 11/12/24 | ||
| 3-Month | |||||
| %Chg | +2.41% since 03/20/23 | +41.91% since 08/21/24 | -67.66% since 08/21/24 | ||
| Low | 0.5124 on 05/30/23 | 0.73 on 10/25/24 | 1.75 on 11/04/24 | ||
| High | 0.5905 on 06/20/23 | 3.89 on 11/13/24 | 9.56 on 08/22/24 | ||
| 6-Month | |||||
| %Chg | +39.42% since 12/20/22 | -8.90% since 05/21/24 | +67.70% since 05/21/24 | ||
| Low | 0.3905 on 12/21/22 | 0.73 on 10/25/24 | 1.09 on 06/18/24 | ||
| High | 0.5905 on 06/20/23 | 4.90 on 05/30/24 | 11.18 on 08/19/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 24,750 | 25,444 | 24,628 | ||
| Shares Outstanding, K | 42,570 | 11,111 | 9,436 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | -62,210,000 | -29,220,000 | -25,970,000 | ||
| Last Quarter Sales | 0 | 0 | 2,790,000 | ||
| Last Quarter Net Income | -5,520,000 | -5,070,000 | -5,820,000 | ||
| 60-Month Beta | -0.73 | 0.58 | 3.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.13 on 11/14/22 | -0.65 on 11/12/24 | -0.91 on 11/12/24 | ||
| Latest Earnings Date | 06/22/23 | 11/12/24 | 11/12/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||